Alana Hippensteele, Lead Editor

This new study showed for the first time that an enzyme, known as fatty acid synthase (FASN), specifically may be responsible for causing cognitive deficits.

On April 24, the CDC published some considerations for clinical providers who are evaluating adolescents for treatment with PrEP.

In outpatient breast cancer clinics, oral chemotherapies are becoming more common for various malignancies, but hematologic and non-hematologic toxicities can cause challenges for patients.

Oral oncolytics has become increasingly common as treatment for patients with cancer over the past several years.

According to a new study, even the sickest patients with COVID-19 who require ventilators in ICUs improve when given treatment that follows existing guidelines for respiratory failure.

In a new study, researchers analyzed gut microbiota to understand further the links between gut health and obesity.

FDA recently released new temporary guidelines on non-standard PPE practices for sterile compounding by pharmacy compounders during the COVID-19 pandemic.

"Approximately 40% of melanomas are considered to be ‘cold,’ meaning that they lack sufficient infiltration of immune cells within the tumor."

Researchers may be able to isolate reservoir cells from patients using the CD127 protein, which would make it possible to study what allows the cells to silence and reactivate the virus .

In a new study, researchers analyzed data on cancer survivors' experiences with financial toxicity and found that survivors have unmet needs in its management.

The Israel Institute for Biological Research presented the country’s Defense Minister Naftali Bennet with a “significant breakthrough” in the search for an antidote to COVID-19 on Monday night.

Although lifesaving drugs became available around 1998 to treat hepatitis C, they were expensive, which limited access for some patients.

A research team has developed wirelessly-driven “smart contact lens” technology that is able to detect diabetes and treat diabetic retinopathy just through wearing them.

A recent study presented a risk prediction model that effectively combined genetic and clinical factors with circulating biomarkers to identify people with a higher than normal risk of pancreatic cancer.

A new collaboration agreement was made between Moderna, Inc, and Lonza Ltd, to manufacture Moderna’s mRNA vaccine against the coronavirus disease 2019.

The FDA has granted Bio-Rad Laboratories Emergency Use Authorization for the company’s SARS-CoV-2 Total Ab test.

The results of the ongoing trial were presented at the 2020 American Association for Cancer Research Virtual Annual Meeting I.

According to new research, biomarkers that signal whether a patient's cancer treatment may be harming their heart have been identified.

Jeremy Sasser, CPhT, pharmacy content strategist for the National Healthcareer Association, discusses the role of technicians during and after COVID-19.

New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.

In a lecture at the virtual Community Oncology Conference 2020, Christine Roussel discussed some clinical considerations for the use of medical cannabis in patients with cancer.

A study recently investigated uterine serous carcinoma in order to more quickly identify those patients with an advanced form of the disease and find the appropriate treatment method for them.

Pharmacist Moms Group founder Suzanne Soliman, PharmD, BCMAS, speaks on the power of social media in the field of pharmacy in the age of COVID-19.

An expert panel at the Community Oncology Conference 2020 discussed how COVID-19 is changing the future of community oncology.

A new study showed that most women living with HIV that were interviewed preferred long-acting injectable adherence to antiretroviral therapy over daily pills.

A new study indicates that treatment with hydroxychloroquine increases overall mortality in patients hospitalized with COVID-19.

Using CRISPR technology, researchers conducted a study aimed at identifying genes that fuel leukemia growth, in order to find new vulnerabilities in chronic myeloid leukemia that can be targeted.

In preliminary data from the trial evaluating dostarlimab, the results demonstrated that the clinical activity in patients with previously treated recurrent or advanced mismatch repair (MMR)-deficient endometrial cancer had an acceptable safety profile.

The new expanded approval was based on positive results from the phase 3 E1912 study.

Treatment of ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors has a high out-of-pocket cost for patients, with substantial variation among them, according to a study.